DALLAS, May 10, 2019 (GLOBE NEWSWIRE) — — North American Cannabis Holdings, Inc. (USOTC: USMJ) (“USMJ”) and Priority Aviation (name change pending) (USOTC: PJET) (“PJET”) today announced that the two companies remain committed to the previously announced dividend of PJET stock to USMJ shareholders in conjunction with the spinoff of USMJ’s AmeriCanna Cafe business to PJET. USMJ announced earlier this week that on Tuesday, next week, May 14, 2019, CEO Steven Rash will publish an update on the state of the company’s transition into a dedicated cannabis logistics operation. The update will include details on the company’s growing Ecommerce sales from their site www.USMJ.com. The update will also include an update on where management is on the dividend and what the companies are doing next to promptly execute the dividend.
The current primary initiative at PJET is to launch the AmeriCanna Cafe in Colorado in a partnership with West Coast Venture Group (OTCQB: WCVC) (“WCVC”) the owner and operator of the $3 million Colorado based Illegal Burger chain. WCVC and USMJ were featured yesterday by Born2Invest, a digital news organization dedicated to writing about and publishing the business and financial affairs of the world. The article, Cannabis companies set to rule the edibles market in 2019, highlights WCVC’s plans with USMJ to launch a cannabis themed restaurant.
After years of cannabis sector business incubation, USMJ transitioned late last year into focusing on cannabis sector logistics services. To demonstrate the caliber of their logistics capabilities, the company launched its www.USMJ.com Ecommerce site. Sales have been steadily growing since the launch and the product line available at www.USMJ.com continues to also grow. USMJ Ecommerce products today include Hemp4mula CBD Gum from Kali-Extracts (USOTC: KALY) and EVERx CBD Sports Water from Puration (USOTC: PURA).
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
CEO North American Cannabis Holdings, Inc.